When someone asks whether platelet-rich plasma (PRP) is helping their hair, a casual before-and-after photograph can be misleading. Hair length, styling, lighting and even a few weeks of normal shedding may change how the scalp looks. A better approach is to establish a baseline and measure change consistently, while recognizing that PRP outcomes vary and evidence remains imperfect.
Why ordinary selfies are unreliable
A bright overhead light makes the scalp more visible than diffuse lighting. Wet or parted hair looks thinner than dry, styled hair. A different camera angle can hide or exaggerate the crown. Even a haircut can make density appear different. None of these visual changes proves that follicles have grown or disappeared.
Standardized clinical photographs have been used in hair-loss studies to compare the same scalp regions over time. A published technique in the Journal of the American Academy of Dermatology describes overlay photography to improve repeatability. The principle is simple: keep the setup as similar as possible.
A practical baseline photography plan
Before treatment, record the frontal hairline, mid-scalp, crown or vertex and relevant side views. Use the same background, camera distance, lens, lighting, head position and hair part on follow-up visits. Note whether hair is wet, dry, colored or styled, and avoid switching between those conditions. Patients should give appropriate consent for storage and any separate use of images; consent to clinical photography is not consent to marketing.
When possible, mark consistent anatomical landmarks so the same regions can be compared. A time-stamped series is more informative than choosing the most flattering image from each visit. Photographs should remain unretouched for clinical comparison.
Measurements beyond photography
Hair density: The number of hairs in a measured area may be assessed with standardized scalp imaging or phototrichogram methods. Results depend on technique and which region is sampled.
Hair shaft diameter: Measuring thickness may help distinguish changes in miniaturization from simple differences in hair length. A treatment could affect count and diameter differently.
Clinical pattern and symptoms: Documenting recession, diffuse thinning, shedding and scalp inflammation matters. Not all hair loss is androgenetic alopecia, and treating the wrong diagnosis can make any intervention appear ineffective.
Patient experience: Styling ease and perceived shedding matter to patients, but subjective improvement should be considered alongside objective measurements rather than replacing them.
What does the evidence actually show?
A 2024 systematic review of PRP for male androgenetic alopecia included eight randomized trials and one cohort study, with 291 participants. Several studies reported improved hair counts or density, but the reviewers emphasized heterogeneity, small samples and methodological limitations. Results from one PRP preparation or injection protocol cannot be assumed for another.
That is why measurement quality matters. A clinic should be able to discuss what outcome it is tracking, how consistently it measures it and what constitutes meaningful improvement. PRP for androgenetic alopecia should not be represented as an FDA-approved hair-growth drug; the evidence and regulatory status differ from those of approved medications.
When should results be assessed?
Hair growth cycles unfold over months. Assessing a photograph immediately after injections is not meaningful evidence of new hair growth. A clinician may arrange serial assessments over several months and reconsider the diagnosis or plan if there is continuing progression or no measurable benefit. There is no universally established PRP schedule that fits every patient, and more sessions do not guarantee better results.
What if the photos do not improve?
Review the original diagnosis, baseline severity, adherence to any concurrent therapy, nutritional or endocrine contributors when indicated, and whether images were taken consistently. Patients with scarring alopecia or significant inflammatory disease need appropriate specialist evaluation; PRP should not delay diagnosis. If objective measures are stable but the patient reports dramatic shedding, investigate that discrepancy rather than assuming treatment success or failure.
For an overview of the procedure and evidence, see our platelet-rich plasma treatment page. Our article on PRP hair candidates addresses who may be suitable; this article focuses specifically on how to assess response.
Bottom line
Meaningful hair-treatment follow-up requires consistent photos, appropriate diagnosis and, when feasible, objective measurements. It is more trustworthy to explain uncertainty than to promise a fixed percentage of regrowth.
Medical references
- Kim et al. Overlay photography technique for evaluating hair-loss treatment response (J Am Acad Dermatol, 2022).
- Donnelly et al. The role of PRP in androgenetic alopecia: systematic review (J Cosmet Dermatol, 2024).
- Meta-analysis of PRP for androgenetic alopecia (Aesthetic Plast Surg, 2024).
Educational information; no outcome is guaranteed. Hair-loss diagnosis and treatment selection require individualized assessment.
